INT187781

Context Info Confidence 0.24 First Reported 2005 Last Reported 2010 Negated 0 Speculated 0 Reported most in Body Documents 3 Total Number 3 Disease Relevance 1.76 Pain Relevance 0

plasma membrane (Slc11a1) molecular_function (Slc11a1) cellular_component (Slc11a1) biological_process (Slc11a1) lysosome (Slc11a1)

Anatomy Link Frequency bladder 1 Slc11a1 (Rattus norvegicus)

Pain Link Frequency Relevance Heat Neuritis 2 5.00 Pain 1 5.00 abdominal pain 1 5.00 Dysuria 1 5.00

Disease Link Frequency Relevance Heat Cancer 26 97.24 Infection 14 94.72 Mycobacterial Infection 32 93.32 Bladder Cancer 31 91.68 Disease 13 83.04 Recurrence 49 80.80 Carcinoma In Situ 8 77.20 Erythema 2 25.68 Malignant Neoplastic Disease 1 11.08 Cicatrix 10 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Intravesical BCG instillation was conducted once per week for the first 6 weeks after bladder transitional cell cancers were identified in pathological tissue examinations after transurethral resections and then once a month for 3 months.

Positive_regulation (conducted) of BCG in bladder associated with cancer

1) Confidence 0.24 Published 2010 Journal Korean Journal of Urology Section Body Doc Link PMC2855454 Disease Relevance 1.41 Pain Relevance 0

Almost same number of males and females in both groups had exaggerated BCG response (Refer to Table 1).

Positive_regulation (exaggerated) of BCG

2) Confidence 0.19 Published 2005 Journal BMC Infect Dis Section Body Doc Link PMC1274275 Disease Relevance 0.09 Pain Relevance 0

Significant number (78%) of normal children with previous BCG vaccination, who were Mantoux negative and received BCG as a 'diagnostic test' or as revaccination, showed, exaggerated BCG response.

Positive_regulation (received) of BCG

3) Confidence 0.19 Published 2005 Journal BMC Infect Dis Section Body Doc Link PMC1274275 Disease Relevance 0.26 Pain Relevance 0

General Comments

This test has worked.